9 results
REBEL Review 84: Stroke Workflow in 2018 

#stroke #algorithm #cva #neurology #management #protocol
REBEL Review 84: Stroke ... Workflow in 2018 #stroke ... #algorithm #cva ... #neurology #management
Ascites - Diagnosis and Management Summary
Paracentesis studies: cell count + differential, albumin, protein, culture
 • Serum-ascites-albumin-gradient
Diagnosis and Management ... Serum-ascites-albumin-gradient ... (SAAG): > 1.1 g ... suggests higher SBP risk ... Control of ascites, ↑Risk
Stroke Evaluation and Management Algorithm

Clinical suspicion of stroke (BE FAST)
 • Balance loss
 • Eyes: vision
Stroke Evaluation ... and Management ... Algorithm Clinical ... #Management #Algorithm ... differential #neurology #CVA
Stroke - Differential Diagnosis Algorithm and Management
Hemorrhagic:
 • Intracerebral: HTN, Cerebral Amyloid Angiopathy, Trauma, Bleeding Diathesis,
Stroke - Differential ... Diagnosis Algorithm ... and Management ... #CVA #Differential ... #Diagnosis #Algorithm
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor
for acute high risk ... minor ischaemic stroke ... hours after high risk ... Antiplatelet #Therapy #CVA ... #Management #Aspirin
Atrial Fibrillation Management Algorithm and Checklist - CAEP Best Practices
A. Assessment and Risk Stratification
B. Rate or
Atrial Fibrillation Management ... Algorithm and Checklist ... Assessment and Risk ... Stroke Prevention ... #Algorithm #Checklist
Algorithm for Suspected SVC Syndrome

SVC syndrome suspected: Facial/arm/neck edema, distended neck/chest veins, facial plethora, dyspnea, cough,
Algorithm for Suspected ... SVC Syndrome Grading ... SVC #Syndrome #Algorithm ... #diagnosis #management ... Superior #vena #cava
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk ... b) CHF c) CVA ... event, follow ACC algorithm ... • <6mo since stroke ... medical and surgical management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... hematology #diagnosis #management